About Contact Us Careers
Sign In

Oncology Active Pharmaceutical Ingredient Market - Top Companies and Manufacturers

  • Report ID: 4213
  • Published Date: Jun 07, 2024
  • Report Format: PDF, PPT

Companies Dominating the Oncology Active Pharmaceutical Ingredient (API) Landscape

    • Merck & Co. Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Pfizer Inc.
    • Abbott Laboratories
    • Sun Pharmaceutical Industries Ltd.
    • Novartis AG
    • Mylan N.V.
    • GSK plc
    • AbbVie Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Eli Lilli and Company

     

Browse Key Market Insights with Data Illustration:

In the News

  • AbbVie Inc. conducted a survey, Emotional Impact Report, and released the findings from it. This survey included more than 300 chronic lymphocytic leukemia patients that grow out of blood cancer. The survey also offered mental and emotional support to patients living with slow-growing blood cancer.

  • Abbott Laboratories to emerge in a study published in the Lancet Neurology to elaborate on the capability of two blood-based biomarkers to predict the results from traumatic brain injury (TBI) and inform treatment interventions.


Author Credits:  Radhika Pawar


  • Report ID: 4213
  • Published Date: Jun 07, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of oncology active pharmaceutical ingredient is estimated at USD 2.17 Billion.

The oncology active pharmaceutical ingredient (API) market size was over USD 2 Billion in 2023 and is poised to cross USD 4.82 Billion by the end of 2036, growing at more than 7% CAGR during the forecast period i.e., between 2024-2036. Higher prevalence of cancer across the globe and the mounting geriatric population is estimated to majorly boost the market growth.

North America is projected to hold the largest industry share by 2036, impelled by the mounting prevalence of cancer.

Merck & Co. Inc., Pfizer Inc., Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., GSK plc, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Eli Lilli and Company
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample